- Home
- SNY vs WELL Comparison
SNY vs WELL Comparison
Compare SNY & WELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- WELL
- Stock Information
- Founded
- SNY 1994
- WELL 1970
- Country
- SNY France
- WELL United States
- Employees
- SNY N/A
- WELL N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- WELL Real Estate Investment Trusts
- Sector
- SNY Health Care
- WELL Real Estate
- Exchange
- SNY Nasdaq
- WELL Nasdaq
- Market Cap
- SNY 116.5B
- WELL 111.2B
- IPO Year
- SNY N/A
- WELL N/A
- Fundamental
- Price
- SNY $47.43
- WELL $169.17
- Analyst Decision
- SNY Hold
- WELL Buy
- Analyst Count
- SNY 1
- WELL 10
- Target Price
- SNY $65.00
- WELL $166.50
- AVG Volume (30 Days)
- SNY 2.3M
- WELL 2.4M
- Earning Date
- SNY 07-31-2025
- WELL 07-28-2025
- Dividend Yield
- SNY 3.37%
- WELL 1.74%
- EPS Growth
- SNY 118.56
- WELL 67.69
- EPS
- SNY 8.65
- WELL 1.76
- Revenue
- SNY $53,714,621,258.00
- WELL $9,277,824,000.00
- Revenue This Year
- SNY $2.85
- WELL $25.89
- Revenue Next Year
- SNY $6.65
- WELL $12.06
- P/E Ratio
- SNY $5.49
- WELL $96.39
- Revenue Growth
- SNY 15.65
- WELL 31.96
- 52 Week Low
- SNY $44.73
- WELL $114.37
- 52 Week High
- SNY $60.12
- WELL $171.09
- Technical
- Relative Strength Index (RSI)
- SNY 43.53
- WELL 72.23
- Support Level
- SNY $46.14
- WELL $168.78
- Resistance Level
- SNY $47.54
- WELL $171.09
- Average True Range (ATR)
- SNY 0.81
- WELL 2.66
- MACD
- SNY -0.17
- WELL 0.58
- Stochastic Oscillator
- SNY 38.54
- WELL 95.18
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,336 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.